Pilot Study of DFN-11 Injection in Medication Overuse Headache

Trial Profile

Pilot Study of DFN-11 Injection in Medication Overuse Headache

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Jun 2017

At a glance

  • Drugs DFN 11 (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Dr Reddys Laboratories
  • Most Recent Events

    • 11 Jun 2017 Results (n=9) presented at the 59th Annual Scientific Meeting of the American Headache Society
    • 07 Jun 2017 According to a Promius Pharma media release data from this study will be presented at the 59th Annual Scientific Meeting of the American Headache Society (AHS).
    • 19 Dec 2016 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top